ArticlePediatric research2026
Targeted proteomics in late-onset neonatal sepsis: an exploratory analysis.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLate-onset neonatal sepsis (LONS) is a major cause of morbidity and mortality in preterm infants, but early diagnosis remains difficult. We aimed to identify candidate proteomic biomarkers of LONS and evaluate whether these changes could be reproduced by in vitro stimulation.
methodsLongitudinal blood samples were collected from preterm neonates with suspected LONS and non-septic controls in two neonatal intensive care units, at onset and after 24 and 48 hours. In parallel, whole blood from preterm neonates without LONS was stimulated in vitro with E. coli and S. epidermidis. Protein expression was quantified using targeted proteomics.
resultsFifteen neonates with LONS, eight controls, and ten in vitro stimulation samples were included. Sixty-six proteins showed altered expression during LONS. Upregulated proteins were predominantly cytokines and chemokines, whereas downregulated proteins were associated with development, growth, and metabolism. Most alterations normalized within 48 hours. In vitro stimulation reproduced expression changes for a subset of proteins, suggesting direct pathogen-induced immune responses.
conclusionLONS in preterm neonates is associated with dynamic proteomic alterations. Combined clinical and in vitro analyses identified biologically relevant candidate biomarkers that may support future diagnostic and monitoring strategies. Further validation in larger, independent cohorts is required before clinical use. IMPACT: Late-onset neonatal sepsis in preterm neonates is associated with pronounced and dynamic changes in protein expression patterns. Targeted proteomics identified candidate biomarkers related to inflammatory signaling, growth, and metabolic pathways. Longitudinal analyses demonstrated rapid normalization of many proteins within 48 hours after sepsis onset. In vitro stimulation distinguished proteins directly induced by pathogen exposure from secondary systemic responses. The identified proteins may serve as targets for future research into diagnostic and monitoring biomarkers for neonatal sepsis in preterm infants.
Identifiers
42855463What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.